Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dar Aldawa Dv/Iv | Amman | Healthcare | Pharmaceuticals | JOD 41.65M | 9.9x | 0.3 | JOD 1.18 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Consulting Group | Amman | Healthcare | Healthcare Providers & Services | JOD 35.40M | 18.3x | 0.3 | JOD 1.77 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hayat Phat | Amman | Healthcare | Pharmaceuticals | JOD 28.78M | 9.7x | 4.53 | JOD 3.03 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ibn Alhaytham H. | Amman | Healthcare | Healthcare Providers & Services | JOD 14.40M | 342.9x | 3.37 | JOD 0.72 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Philadelphia Pharma Industry | Amman | Healthcare | Pharmaceuticals | JOD 10.95M | 12x | 1 | JOD 1.46 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |